David B. Shackelford
0000-0002-8270-898X
Publication & Citation Trends
Publications
0 total
Abstract 3941: CRISPR screen of human stem cell derived MYC-driven medulloblastoma tumors reveal the mitochondria as a vulnerability
Cited by 0
Semantic Scholar
Macropinocytosis and Vascularization Determine Response to mTOR Inhibitors in Lung Squamous Cell Carcinoma.
Cited by 0
Semantic Scholar
Trafficking of mitochondrial double-stranded RNA from mitochondria to the cytosol OA
Cited by 15
Semantic Scholar
Abstract 3261: Improving targeted therapy in female patients with lung squamous cell carcinoma
Cited by 0
Semantic Scholar
Abstract SY35-02: Spatial mapping of mitochondrial networks in lung cancer
Cited by 0
Semantic Scholar
Targeting Asparagine Metabolism in Well-Differentiated/Dedifferentiated Liposarcoma OA
Cited by 3
Semantic Scholar
N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma OA
Cited by 7
Semantic Scholar
Abstract 422: Cell intrinsic determinants of response to mTOR based therapy
Cited by 0
Semantic Scholar
Research Topics
Immune cells in cancer
(13)
Cancer Immunotherapy and Biomarkers
(12)
Ferroptosis and cancer prognosis
(10)
Chemokine receptors and signaling
(6)
Angiogenesis and VEGF in Cancer
(5)
Affiliations
Salk Institute for Biological Studies
APLA Health
University of California, Los Angeles
UCLA Health
Los Angeles Medical Center